GARLIC PHYTOCHEMICALS POSSIBLE BENEFIT IN HORMONE-RELATED CANCERS
This article was originally published in The Tan Sheet
Executive Summary
GARLIC PHYTOCHEMICALS POSSIBLE BENEFIT IN HORMONE-RELATED CANCERS suggested in several presentations of preliminary findings of studies discussed at the Designer Foods III conference in Washington, D.C. May 23-25. Researcher John Pinto, PhD, Memorial Sloan-Kettering Cancer Center, asserted that "at several sites ...you see that a number of some of the phytochemicals that exist in food can prevent the [cancer] initiation phase. Many of the compounds in foods certainly act as antioxidants and can block the promotion of tumors and certainly can inhibit a number of hormones that impinge on the growth of hormone-sensitive tissues, particularly breast and prostate."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning